Norgestimate And Ethinyl Estradiol Kit
Product Images NDC 50090-2259

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Norgestimate And Ethinyl Estradiol (NDC 50090-2259). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structures (Chem Structures)

Chemical structures of Norgestimate USP and Ethinyl Estradiol USP are shown, depicting the molecular arrangements of these two active ingredients used in the combination drug kit labeled by A-S Medication Solutions.*

FDA Label Image

Fig-c (Fig C)

An instructional diagram depicting the placement or interaction of a fingertip with circular day markers labeled 'SUN' and 'MON.' Arrows labeled 'Start' and 'Week 2' indicate progression, suggesting steps for using a Norgestimate and Ethinyl Estradiol kit by A-S Medication Solutions.*

FDA Label Image

Fig-d (Fig D)

Illustration showing two dosing cards for Norgestimate and Ethinyl Estradiol tablets. Each card displays a 28-day weekly pill schedule, organized by day and week, with a hand demonstrating removal of a tablet from the pack. Dosage strengths indicated are 0.25 mg/0.035 mg and a series of doses from 0.18 mg to 0.25 mg paired with 0.035 mg. Both include a note that the package is not child resistant and to keep medication out of children's reach.*

FDA Label Image

Fig-e (Fig E)

An instructional diagram labeled 'Figure E' showing a hand pointing at a pill blister pack calendar marked with days of the week, specifically Tuesday and Wednesday, indicating the start of medication on Day 1 and progression to Week 2. It visually guides users on how to begin and follow the dosing schedule.*

FDA Label Image

Fig-f (Fig F)

An instructional diagram showing a finger peeling a pill or tablet off a blister pack, with labeled rows for weeks 1 through 4 and columns for Sunday and Monday. The diagram illustrates the sequence of medication use in a weekly calendar format, typically used for a birth control pill kit.*

FDA Label Image

Img1-1 (Img1 1)

An illustrated medication chart showing weekly progression for Norgestimate and Ethinyl Estradiol tablets 0.25 mg/0.035 mg. The chart indicates a 28-day dosing schedule: weeks 1 through 3 contain active blue pills, and week 4 contains inactive light green pills. Each day of the week is marked with circles representing pill intake, with arrows indicating the starting day for each week.*

FDA Label Image

Img1 (Img1)

FDA Label Image

Img2-1 (Img2 1)

Administration diagram for Norgestimate and Ethinyl Estradiol Tablets oral contraceptive kit showing a 4-week pill schedule. Pills vary in color by week: white to off-white, light blue, and blue pills labeled as active for weeks 1 to 3, and light green pills labeled as inactive for week 4. Days of the week are indicated for daily dosing guidance.*

FDA Label Image

Img2 (Img2)

An instructional chart for Norgestimate and Ethinyl Estradiol tablets showing a 4-week daily pill regimen. The illustration displays rows for Week 1 to Week 4, each with seven circles labeled Sunday through Saturday. It identifies different pill colors for each week: white to off-white, light blue, and blue pills as active, and light green pills as inactive.*

FDA Label Image

Img3 (Img3)

An instructional diagram illustrating pregnancy rates per 100 women in one year relative to different birth control methods. It ranks methods from fewer pregnancies (implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones) to more pregnancies (condoms, diaphragm, no sex during fertile days, spermicide, withdrawal) and finally no birth control with the most pregnancies.*

FDA Label Image

Label Image (Lbl500902259)

Norgestimate and Ethinyl Estradiol 0.25 mg/0.035 mg oral tablet kit label from A-S Medication Solutions. The label includes product NDC 50090-2259 and packaging details for one blister card of 28 tablets. Storage instructions indicate to keep at 60 to 77 degrees Fahrenheit and protect from light.*

FDA Label Image

Logo-1 (Logo 1)

FDA Label Image

Logo (Logo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.